1074034

Otsuka Pharmaceutical Development & Commercialization, Inc — FEI 3000718406

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 14, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rockville, MD (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)